Biopharmaceutical protein production plays an increasingly important role in human health, including the treatment and prevention of cancer and immune diseases. With the rapid development of synthetic biology technology, cell-free protein synthesis (CFPS) has been regarded as a powerful tool to manufacture a variety of proteins because of its remarkable advantages over living-cell protein synthesis. Working with an efficient and easily scalable reactor, CFPS can meet the requirements of flexible on-demand protein synthesis. To achieve this goal, a new continuous-flow CFPS platform was developed using a tube-in-tube reactor in this study. Learn More